RK

Rajeev Kumar Giri

Active Director Director DIN 09347271
DIN 09347271 First appointment Aug 2021 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Aug 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajeev Kumar Giri

Data last updated:

Rajeev Kumar Giri is a Director at Ribozelle Meds Private Limited (since 2024) and Designated Partner at Genetico Drugs Llp (since 2021). The companies operate in Paper and Pharma.

DIN 09347271
Primary Designation Director
Industry Paper
First Appointment 21 Aug 2021
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ribozelle Meds Private Limited U21002UT2024PTC017443
Director26 May 20242024Active
Designated Partner21 Aug 20212019Active

Board colleagues of Rajeev Kumar Giri

NameDINCompanyDesignation
Darakshan Yusufi08458973Ribozelle Meds Private Limited , Genetico Drugs LlpDirector

Directorship timeline

Open interactive timeline →
Genetico Drugs Llp
Ribozelle Meds Private Limited
Premium access

Shareholding and investment profile for Rajeev Kumar Giri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajeev Kumar Giri

Rajeev Kumar Giri currently holds 2 directorships: Ribozelle Meds Private Limited (Director, since 26 May 2024); Genetico Drugs Llp (Designated Partner, since 21 Aug 2021).

Rajeev Kumar Giri was first appointed on 21 Aug 2021 as Designated Partner at Genetico Drugs Llp. The most recent appointment on record is 26 May 2024 at Ribozelle Meds Private Limited.

The current boards of Rajeev Kumar Giri's companies include Darakshan Yusufi (Ribozelle Meds Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available